stent deployment) compared to peaking several days postoperatively after CEA. This large retrospective cohort study found that the risk of ICH was significantly higher after CAS (0.85%) than CEA (0.42%). However, this difference may not be clinically significant. This discrepancy in ICH was not due to differences in preprocedure antiplatelet or anticoagulant. Many factors were not assessed, such as the degree of contralateral disease, plaque characteristics, and, most importantly, postprocedure dual antiplatelet therapy, which the authors agree was almost certainly higher in stented patients. A review of patients who underwent CEA in the Vascular Quality Initiative showed that dual therapy with aspirin and clopidogrel was associated with increased reoperation for bleeding (P ¼ .003), but the risk of ICH was not addressed.
Ipsilateral antegrade approach for endovascular interventions should be the preferred approach e Not so fast! Key findings: A total of 556 patients underwent femoropopliteal angioplasty with 461 (82%) performed via AA. AA patients had a lower body mass index (26 vs 29; P ¼ .005). No significant difference was seen in periprocedural (15.8% AA vs. 11.6% RA) or access site complications (3.7% AA vs. 1.1% RA). There was less need for a closure device (40.3% AA vs 73% RA; P < .01), less contrast (94 mL AA vs 114 mL RA; P < .001), and less radiation (3487 cGy cm 2 AA vs 9697 cGy cm 2 RA; P < .001) with AA. AA was also associated with greater technical success (83.8%) of treating the lesion than RA (73.3%; P ¼ .002).
Conclusion: Ipsilateral antegrade femoral access is associated with higher technical success and reduced contrast and radiation doses, with no significant difference in complications compared to contralateral retrograde femoral arterial access.
Commentary: There are four reasons contralateral RA is favored for lower extremity arterial endovascular interventions compared to AA. First, imaging of the aortoiliac arteries to rule out occlusive disease is possible with RA and not with AA. Second, the authors agree in the manuscript that RA is technically easier to perform. Third, the authors agree RA has a favorable orientation for superficial femoral artery selection. Fourth, bleeding complications and the need for emergent femoral artery repair are lower with contralateral RA. The authors found that AA was associated with less contrast and radiation than RA. But, to rule out proximal aortoiliac occlusive disease, they must either obtain computed tomography angiography, which requires more contrast and radiation than an aortoiliac arteriogram or rely on noninvasive studies. From a technical stand point, it is impossible to perform AA in very obese patients, even after taping the pannus proximally. Even the authors preferred RP in these patients as evidence by a lower body mass index in the AA group. The authors also favored RA for emergency cases (Why? It's easier and faster). AA has a definite disadvantage in terms of orientation for superficial femoral artery cannulation. Lastly, the authors did not find significant differences in periprocedural (15.8% AA vs 11.6% RA) or access site complications (3.7% AA vs 1.1% RA), but there certainly was a trend showing higher complications with AA (most likely a type II statistical error). The authors used closure devices more commonly with RA, but this was a self-fulfilling prophecy. In the manuscript, they stated they used manual pressure for 4F sheaths and closure devices for 6F sheaths but noted 4F sheaths were most commonly used for AA and 6F sheaths for RA. The authors have not convinced me, and hopefully not the reader, that AA is the preferred approach for lower extremity endovascular interventions.
